Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Syngen Biotech Co., Ltd. (8279:TWSE), powered by AI.
Syngen Biotech Co., Ltd. is currently trading at $97.90. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Syngen Biotech Co., Ltd. on Alpha Lenz.
View Syngen Biotech Co., Ltd.'s valuation metrics on Alpha Lenz.
“Syngen Biotech Co., Ltd.'s ROE is 11.8%. Explore profitability and growth together.”
Ask for details →Syngen Biotech Co., Ltd. is a biotechnology company specializing in the manufacture and sale of microbial pharmaceuticals and biochemical nutrition products. Established in 1999 and headquartered in Tainan, Taiwan, the company focuses on advanced processes such as strain identification, microorganism fermentation, and purification. Its product portfolio includes active pharmaceutical ingredients, nutritional components, biological fermentation products, as well as functional foods for both human health and applications in agriculture and aquaculture. Syngen Biotech serves a critical role in the health technology sector, supplying essential raw materials and specialized solutions to food, pharmaceutical, and agritech industries. With a sizable market capitalization and consistent financial performance, the company demonstrates its importance as a supplier of biotechnological innovations that support nutrition, medical therapies, and sustainable agricultural practices.
“Syngen Biotech Co., Ltd.'s ROE is 11.8%. Explore profitability and growth together.”
Ask for details →Syngen Biotech Co., Ltd. (ticker: 8279) is a company listed on TWSE in the Healthcare sector (Biotechnology).
The current price is 97.9 with a P/E ratio of -x and P/B of -x.
ROE is 11.78% and operating margin is 15.16%. Annual revenue is $2.1B.